Established Leadership and Reputation: Founded in 1993, Martin and Harris Laboratories Ltd. has established itself as a leading pharmaceutical company in India, renowned for its research and manufacturing of finished dosage forms.
State-of-the-Art Manufacturing Facilities: With state-of-the-art manufacturing facilities strategically located across India, including Roorkee and Gagret, Martin and Harris ensures stringent adherence to WHO GMP guidelines, offering diverse dosage forms and specialty formulations.
Innovative R&D Capabilities: The company operates a center of excellence for research and development in Gurugram, focusing on formulation and API development, analytical development, and quality assurance, fostering continuous innovation in pharmaceuticals.
Strategic Partnerships and Alliances: Martin and Harris Laboratories has formed strategic alliances with Walter Bushnell for marketing and manufacturing, enhancing their capabilities in innovative pharmaceutical therapies and market expansion.
Investment thesis: Martin and Harris Laboratories Ltd., a key player in India's pharmaceutical industry since 1993, excels in producing a wide range of high-quality medicines. Their state-of-the-art facilities in Roorkee and Gagret meet international standards for manufacturing, ensuring top-notch quality. Strategic partnerships, like with Walter Bushnell, help them expand their market reach and innovate. Their research center in Gurugram focuses on developing new medicines and improving existing ones. With a recent 10% increase in revenue and a focus on expanding contract manufacturing, Martin and Harris is well-positioned for continued growth in the competitive pharmaceutical market.
Conclusion: The company's current P/E ratio stands at 5.7x, significantly lower than the average of 45x among comparable peers of similar size. There is potential for enhanced valuation through strategic initiatives such as expanding into international markets and forging partnerships with leading pharmaceutical companies for contract manufacturing.
Quantity
Invest
, Min. Investment: ₹